Skip to content
healthcare.dev

Neulasta

NDC 55513-190, pegfilgrastim, injection, from Amgen, Inc.

Product NDC
55513-190
Status
Listed
Labeler
Amgen, Inc
Dosage form
INJECTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA125031
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/55513-190 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • PEGFILGRASTIM6 mg/.6mL

Pharmacologic classes

Granulocyte Colony-Stimulating Factor [CS]; Increased Myeloid Cell Production [PE]; Leukocyte Growth Factor [EPC]

Package NDCNDC-11Package
55513-190-01555130190011 SYRINGE in 1 CARTON (55513-190-01) / .6 mL in 1 SYRINGE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/fdfe5d72-6b80-435a-afa4-c5d74dd852ce
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=55513-190

Use it

Look up 55513-190 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/55513-190 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 55513-190. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.